Biotech China 2014

View Profile

Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2010 Combining nutrition, food science and engineering in developing solutions to Inflammatory bowel diseases omega-3 polyunsaturated fatty acids as example. Food & Funct., 2010, Advance ArticleDOI: 10.1039/C0FO00057D
2. 2010 Chronic inflammation, mutation and human disease Mutat. Res., 2010 Jun 23. [Epub ahead of print] PubMed PMID: 20600166.
3. 2010 Nutrigenomics and inflammatory bowel diseases Crit Rev. Clin. Immunol. 6(4):573-83..
4. 2010 Dietary influences on mutagenesis-where is this field going? Environ. Molec. Mutagen. DOI: 10.1002/em.20594.
5. 2010 Quinazolines as novel anti-inflammatory histone deacetylase inhibitors Mutat. Res., Mutat Res. 2010 Jun 15. [Epub ahead of print] PubMed PMID: 20558185.
6. 2010 Obesity and diabetes genes are associated with being born small for gestational age: Results from the Auckland Birthweight Collaborative study BMC Medical Genetics, 2010, 11:125.
7. 2010 Tailoring foods to match people's genes in New Zealand: opportunities for collaboration World Rev Nutr Diet. 101:169-75. Epub 2010 Apr 30. PubMed PMID: 20436263.
8. 2010 Genome-wide association studies and diet. World Rev Nutr Diet.101:8-14. Epub 2010 Apr 30. PubMed PMID: 20436248.
9. 2010 PTPN2 but not PTPN22 is associated with Crohn's disease in a New Zealand population. Tissue Antigens. 2010 Apr 13. [Epub ahead of print] PubMed PMID: 20403149.
10. 2010 15-Week Long School-Based Nutrition Education Program to Promote Italian Primary Schoolchildren's Fruit and Vegetable intake in press.
11. 2010 Association analysis of 3p21 with Crohn's disease in a New Zealand population Hum Immunol. 2010 Mar 19. [Epub ahead of print] PubMed PMID: 20307617.
12. 2010 Traditional foods reported by a community in 2004 associations with occasion. MAI review, 2010. 2. 1-10..
13. 2010 Using metabolomic analysis to understand inflammatory bowel diseases. Inflammatory Bowel Diseases, 2010 Jul 13. [Epub ahead of print] PubMed PMID: 20629098.c
14. 2010 Nutrigenomics and clinical nutrition Complete Nutrition, 6, 13-15
15. 2010 Chronic inflammation and mutagenesis. Mutat Res. 2010 Mar 16. [Epub ahead of print] PubMed PMID: 20223251.
16. 2010 Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens. Biometals. 2010 Mar 9. [Epub ahead of print] PubMed PMID: 20217186.
17. 2010 Evaluation of the cytoprotective effects of bovine lactoferrin against intestinal toxins using cellular model systems Biometals. 2010 Feb 16. [Epub ahead of print] PubMed PMID: 20157763.
18. 2010 Dietary factors in chronic inflammation: Food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population Mutat Res. 2010 Feb 6. [Epub ahead of print] PubMed PMID: 20144628.
19. 2010 Metabolomic Analysis Identifies Inflammatory and Noninflammatory Metabolic Effects of Genetic Modification in a Mouse Model of Crohn's Disease J Proteome Res. 2010 Mar 3. [Epub ahead of print] PubMed PMID: 20141220
20. 2010 Genetic factors in chronic inflammation: Single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population Mutat Res. 2010 Jan 28. [Epub ahead of print] PubMed PMID: 20109474.
21. 2010 Food-derived bioactives as potential regulators of the IL-12/IL-23 pathway implicated in inflammatory bowel diseases. Mutat Res. 2010 Jan 11. [Epub ahead of print] PubMed PMID: 20067801
22. 2010 Regulation of gene expression as an anticancer drug target. Current Cancer Drug Targets, in press
23. 2010 One year sustainability of risk factor change from a 9 week workplace intervention, J Environ Public Health 2009:569104. Epub 2010 Feb 10. PubMed PMID: 20169118
24. 2010 Interactions between genes and diet in the etiology of colorectal cancer. World J Gastrointest Oncol 2(3):125-129.
25. 2010 Environmental factors in the development of chronic inflammation: A case-control study on risk factors for Crohn's disease within New Zealand. Mutat Res. 2009 Sep 12. [Epub ahead of print]
26. 2010 Meat and cancer. Meat Science, 84(2):308-13.
27. 2010 The micronutrient genomics project: creating a community driven knowledge base for micronutrient research in press.
28. 2009 Genetic association study of MDR1 and inflammatory bowel disease reveals partial protective effect of heterozygous variants in ulcerative colitis Inflammatory Bowel Diseases, Aug 14. [Epub ahead of print] PMID: 19685447.
29. 2009 Epigenetic Variation and Customising Nutritional Intervention. Current Pharmacogenomics and Personalized Medicine, 7 (2) 115-124.
30. 2009 Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to Inflammatory Bowel Diseases in a New Zealand Caucasian population: a case-control study BMC Research Notes 2:52 (27 March 2009)
31. 2009 Role of dietary mutagens in cancer and atherosclerosis Current Opinion in Clinical Nutrition and Metabolic Care, 12(4):343-9.
32. 2009 Non-targeted urinary metabolite profiling of a mouse model of Crohn's disease J Proteome Res. 8(4):2045-2057.
33. 2009 Mushroom intolerance: a novel diet-gene interaction in Crohn' s disease Br. J. Nutr., 102(4):506-8.
34. 2009 Tumor necrosis factor receptor superfamily, member 1B (TNFRSF1B) haplotypes increase or decrease the risk of Inflammatory Bowel diseases in a New Zealand Caucasian population Gastroenterology Research and Practice, 2009:591704. Epub 2009 May 3. PubMed PMID: 19421420
35. 2009 Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort Hum Immunol. 2009 Mar 7. [Epub ahead of print]. PMID: 19275920
36. 2009 Kiwifruit-based polyphenols and related antioxidants for functional foods: Kiwifruit extract-enhanced gluten-free bread International Journal of Food Sciences and Nutrition, Int J Food Sci Nutr. 2009 Jun 22:1-14. [Epub ahead of print]
37. 2009 Anthocyanidin-containing compounds occur in the periderm cell walls of the storage roots of sweet potato (Ipomoea batatas J. Plant Physiol., 166(10):1112-7
38. 2009 Nutrigenomics Approaches to Functional Foods Journal of the American Dietetic Association, 209, 452-458
39. 2009 Dietary Protection against Free Radicals: A Case for Multiple Testing to Establish Structure-activity Relationships for Antioxidant Potential of Anthocyanic Plant Species International Journal of Molecular Sciences 10 (3), 1081-
40. 2009 Role of gut microbiota in Croh' s disease Expert Rev Gastroenterol Hepatol. 3(5): 535-46.
41. 2009 Characterisation of single nucleotide polymorphisms relevant to Inflammatory Bowel Diseases in commonly-used gastrointestinal cell lines, Inflamm Bowel Dis 2009 Aug 3. [Epub ahead of print] PMID: 19653290.
42. 2008 Single nucleotide polymorphisms in IL4, OCTN1 and OCTN2 genes in association with Inflammatory Bowel Disease phenotypes in a Caucasian population in Canterbury New Zealand. The Open Gastroenterology Journal, 2, 50-56.
43. 2008 Green tea and ovarian cancer Southern Medical Journal, rapid response posted 20 May, 2008
44. 2008 Gender-stratified analysis of DLG5 R30Q in 4707 Crohn's disease patients and 4973 controls from 12 Caucasian cohorts. J. Med. Genet. 45, 36-42.
45. 2008 Allantoin as a Biomarker of Inflammation in an Inflammatory Bowel Disease Mouse Model: NMR Analysis of Urine The Open Bioactive Compounds Journal, 1, 1-6
46. 2008 Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population Dig Liver Dis. 2008 Apr 2. [Epub ahead of print] PMID: 18394979 [PubMed - as supplied by publisher]
47. 2008 Nutrition and mutagenesis Annu Rev Nutr. 28, 313-329
48. 2008 Is the dietary fibre concept becoming too hard to digest? (Invited commentary). Br J Nutr. 2008 Feb 29;:1-2 [Epub ahead of print]
49. 2008 SNPs in the Tumor necrosis factor-alpha gene affect Inflammatory bowel diseases risk World Journal of Gastroenterology 14, 4562-4661.
50. 2008 Dissecting the nutrigenomics, diabetes and gastrointestinal disease interface: From risk assessment to health intervention OMICS 12(4):237-44.
51. 2007 Genotoxicity of non-covalent interactions: DNA intercalators Mutat. Res.: Fundam. Mol. Mech. Mutagen., doi:10.1016/j.mrfmmm.2007.03.014
52. 2007 Nutrigenomics in the whole-genome scanning era: Crohn s Disease as example Cell Mol Life Sci. 64, 3105-18.
53. 2007 Has toll-like receptor 4 been prematurely rejected as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. American Journal of Gastroenterology 102(11):2504-12
54. 2007 Tri-allelic SNPs and genotyping error in genetic epidemiology studies - MDR1 (ABCB1) G2677/T/A as an example. Cancer Epidemiol Biomarkers Prev 16(6):1185–92
55. 2007 Nutrigenomics and gut health Mutation Res. 622, 1-6
56. 2007 Genes diet and inflammatory bowel disease Mutation Res. 622, 70-83
57. 2007 Genetic variation in human disease, and a new role for copy number variants Mutation Res. 622, 33-41.
58. 2007 Cell culture models in developing nutrigenomics foods for inflammatory bowel disease Mutation Res. 622, 94-102
59. 2007 Genetic epigenetics, nutrition and chronic disease, Agro FOOD Industry High-tech, 3, 49-51.
60. 2007 Genetic studies of inflammatory bowel disease Agro FOOD Industry High-tech, 3, 16-19.
61. 2007 Cancer chemoprevention by dietary bioactive components that target immune response Current cancer drug targets, 7, 325-334
62. 2007 Non-Covalent Ligand/DNA Interactions: Minor Groove Binding Agents Mutat. Res.: Fundam. Mol. Mech. Mutagen., doi:10.1016/j.mrfmmm.2007.03.012
63. 2007 Modelling inflammatory bowel disease: the zebrafish as a way forward. Expert Review Molecular Diagnostics 7(2):177-93
64. 2007 Uncoupling gene-diet interactions in inflammatory bowel disease Genes and Nutrition, 2, 55-57.
65. 2007 Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant Inflammatory Bowel Diseases 13(9) 1069 1076.
66. 2006 Nutrigenomics: integrating genomic approaches into nutrition research. Molecular Diagnosis & Therapy, 10(2) 101-108
67. 2006 Thioredoxin reductase and glutathione peroxidase activity in relation to selenium intake in a group of New Zealand men at high prostate cancer risk J. Nutr., 136, 2232-2235
68. 2006 The role of Therapeutic Goods Administration (TGA) and Medicine and Medical Devices Safety Authority (Medsafe) in evaluating complementary and alternative medicines in Australia and New Zealand Toxicology, 221 (1), pp. 88-94
69. 2006 Frameshift Mutations Induced by Four Isomeric Nitroacridines and Their des-Nitro Counterpart in the lacZ Reversion Assay in Escherichia coli. Environ. Molec. Mutagen. 47 (2), pp. 82-94
70. 2006 votre partenaire sant. Phytotherapie, 2, 87-92
71. 2006 Antioxidant activities of extracts from traditional Maori food plants NZ J Bot., 44, 1-4
72. 2006 Kiwifruit consumption reduces DNA fragility: a randomised controlled pilot study in volunteers Nutrition Research, 26, 197-200.
73. 2005 Does a diet rich in dietary fibre really reduce the risk of colon cancer? Digestive and Liver Disease. 317, 139-141.
74. 2005 Dietary Fibres and Human Health. Mol. Nutr. Food Res., 49, 517-518.
75. 2005 Dietary fibres as prebiotics Implications for colorectal cancer Environ. Mol. Nutr. Food Res., 49, 609-619.
76. 2005 Production and characterisation of two wheat-bran fractions: an aleurone-rich and a pericarp-rich fraction. Mol. Nutr. Food Res., 49, 536-545.
77. 2005 Overview of mechanisms of cancer chemopreventive agents Mutation Res, 591, 8-15
78. 2005 Interlaboratory Validation of a CD71-Based Flow Cytometric Method (MicroFlow) for the Scoring of Micronucleated Reticulocytes in Mouse Peripheral Blood Environmental and Molecular Mutagenesis, 45, 44-55.
79. 2005 Multiple drug resistance, antimutagenesis and anticarcinogenesis Mutation Res, 591, 24-33.
80. 2005 Demonstration by real-time PCR that cellular DNA alkylation by novel aminoindoline compounds affects expression of the proto-oncogene, c-MYC. Chemical Research in Toxicology. 18, 239-48
81. 2005 The case for strategic international alliances to harness nutritional genomics for public and personal health Br. J. Nutr. 94, 623-632.
82. 2005 Giorgio Bronzetti (1939-2005) Mutation Res. 591, 1-2.
83. 2005 Mechanistic Approaches to Chemoprevention of Mutation and Cancer Mutation Res, 591, 3-7.
84. 2005 Antioxidant and antigenotoxic effects of plant cell wall hydroxycinnamic acids in cultured HT-29 cells. Mol. Nutr. Food Res., 49, 585-593
85. 2004 Immunutrition and cancer Mutation Research 551, 29-42.
86. 2004 Diet and cancer prevention using antimutagens? Toxicology 198, 147-159.
87. 2004 Mechanisms by which resistant starches and dietary fibres affect the metabolism and disposition of the food carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) J. Chromatog. B., 802 (1), 201-210.
88. 2004 DNA Stability and Serum Selenium Levels in a High Risk Group for Prostate Cancer Cancer Epidemiology, Biomarkers and Prevention. 13(3), 201-207.
89. 2004 DNA and the chromosome varied targets for chemotherapy. Cell & Chromosome, 3:2-20.
90. 2004 In situ and in vitro antioxidant activity of sweetpotato anthocyanins Journal of  Agricultural and Food Chemistry. 44, 36-43
91. 2004 Nutrigenomics and the New Zealand Food Industry. Food New Zealand. April, 29-36.
92. 2004 Epigenetic events and protection from colon cancer in New Zealand. Environ. Molec. Mutagen. 44, 36-43.
93. 2004 Nutrition and carcinogenesis Mutation Res 551, 1-8
94. 2003 NEW Zealand fertile ground for functional foods and nutrigenomics. Nutritional genomics and functional foods., 1, 23-28.
95. 2003 Citrus Pectin and Oligofructose Improve Folate Status and Lower Serum Total Homocysteine in Rats Int J. Vit & Nutr. Res., 73, 403-409.
96. 2003 Bacterial antimutagenesis by hydroxycinnamic acids from plant cell walls Mutation Research 542, 49-58.
97. 2003 Are kiwifruit really good for you? Acta Horticulturae, 610, 131-135.
98. 2003 Mode of cell death by some sequence selective DNA minor groove binding nitrogen mustards in Chinese hamster cells: comparison with untargeted mustards and with Hoechst 33342 Oncology Research and Anticancer Drug Design, 13, 491-512.
99. 2003 Enhanced coloration reveals high antioxidant potential in new sweetpotato cultivars J.Sci. Food Agric.,83, 1076-1082.
100. 2003 The dietary fibre debate: more food for thought The Lancet, 361, 1487-1488
101. 2003 Contrasting effects of non-starch polysaccharide and resistant starch-based diets on the disposition and excretion of the food carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), in a rat model. Food Chem. Toxicol., 41, 785-792.
102. 2003 Basic requirements for a scientific paper reporting antioxidant, antimutagenic or anticarcinogenic potential of test substances, Food Chem Toxicol, 41, 603-610
103. 2003 Effect of smoking habit on the frequency of micronuclei in human lymphocytes: results from the Human MicroNucleus projec Mutation Res 543 (2): 155-166
104. 2003 Dietary and medicinal antimutagens and anticarcinogens: Molecular mechanisms and chemopreventive potential. Highlights of a symposium. Mutation Res, 523-524, 1-9
105. 2003 Functional foods in the traditional Maori diet Mutation Res., 523-524, 109-118.
106. 2002 The effect of DNA-alkylating agents on gene expression from two integrated reporter genes in the cell line EMT6 Anticancer Drugs, 13, 271-280.
107. 2002 Kiwifruit promotes laxation in the elderly Asia Pacific J. Clin. Nutr., 11, 164-168
108. 2002 Natural and human-made mutagens and carcinogens in the human diet Ferguson, LR.
109. 2002 Meat consumption, cancer risk and population groups within New Zealand Mutation Research, 506-7, 215-224
110. 2002 Highlights of the 8th International Conference on Carcinogenic/Mutagenic N-Substituted Aryl Compounds Mutation Res., 506-7, 1-8.
111. 2002 Intra- and inter-laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide-scoring exercise by the HUMN projec Mutation Research, 534: 45-64
112. 2001 Antimutagenesis /anticarcinogenesis 2001: Screening, methods and biomarkers Mutation Res, 496, 1-4
113. 2001 Contrasting effects of acute and chronic dietary exposure to 2-amino-3-methyl-imidazo[4,5-f]quinoline on xenobiotic metabolising enzymes in the male Fischer 344 Rat: implications for dietary chemoprevention studies Eur. J. Nutr. 40, 39-47.
114. 2001 Vitamins/minerals and genomic stability in humans Mutation Res, 475, 1-7.
115. 2001 The role of plant polyphenols in genomic stability Mutation Res. 475, 112-133.
116. 2001 The irreversible tyrosine kinase inhibitor CI-1033 shows receptor enhanced chemosensitivity in combination with cisplatin Anticancer Drugs, 12,683-690.
117. 2001 Flow Cytometric Enumeration of Micronucleated Reticulocytes: High Transferability Among 14 Laboratories Environ Molec Mutagen, 38, 59-68.
118. 2001 Changing concepts of dietary fiber: implications for carcinogenesis Nutrition and Cancer, 39, 155-169.
119. 2001 Antimutagenesis/ anticarcinogenesis 2001: Mechanistic studies Mutation Res, 480-481, 1-7.
120. 2000 Comparative effects of three resistant starch preparations on transit time and short chain fatty acid production in rats Nutrition and Cancer, 36, 230-237
121. 2000 Special issue - Protocols in mutagenesis Mutat Res 455, 1-2.
122. 2000 Human micronucleus project: International database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: 1. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei Environ. Molec. Mutagen. 37, 31-45
123. 2000 Role of DNA minor groove alkylation and DNA crosslinking in the cytotoxicity of polybenzamide mustards Anticancer Drug Design 15, 245-253.
124. 2000 Antimutagenic effects of wheat bran diet through modification of xenobiotic metabolising enzymes Mutation Res., 454, 77-88.
125. 2000 Effects of two contrasting dietary fibres on starch digestion, short chain fatty acid production and transit time in rats J.Sci. Food Agric., 80, 2089-2095.
126. 2000 The mutagenic spectrum of acridine-linked aniline nitrogen mustards in AS52 cells: implications of DNA-targeting with high selectivity for adenine or guanine bases Mutation Res., 469, 115-126.
127. 2000 Transcriptional blockages in a cell-free system by sequence-selective DNA alkylating agents Chem,Biol. Interactions, 126, 15-31.
128. 2000 Mutations induced by some DNA minor groove binding alkylators in AS52 Chinese hamster cells Mutation Res., 448, 35-46.
129. 2000 The study of antigenotoxic effects of dietary fibre is lost in a confused concept Mutation Research, 447, 319-322.
130. 2000 Biochemical evidence that high concentrations of the antidepressant amoxapine may cause inhibition of mitochondrial electron transport Toxicol. Appl. Pharmacol. 93, 118-126
131. 1999 Antimutagens in food plants eaten by Polynesians: micronutrients, phytochemicals and protection against bacterial mutagenicity of the heterocyclic amine, 2-amino-3-methylimidazo[4,5-f]quinoline Food Chem. Toxicol. 37: 95-103, 1999.
132. 1999 Protection against cancer by wheat bran: role of dietary fibre and phytochemicals Eur. J. Cancer. Prev. 8, 17-25
133. 1999 Natural and man-made mutagens and carcinogens in the diet Mutat. Res. 443, 1-11.
134. 1999 Dietary fibres may protect or enhance carcinogenesis Mutat. Res. 443, 95-110.
135. 1999 Studies on the mechanism of cancer protection by wheat bran: effects on the absorption, metabolism and excretion of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ Carcinogenesis 20, 2253-60.
136. 1999 Wheat bran and cancer: the role of dietary fibre Asia Pacific J. Clin. Nutr 8(Supp), S41-S46.
137. 1999 Prostate cancer risk and meat cooking methods J. Natl. Cancer. Inst., 191, 2038-2044
138. 1999 Polybenzamide mustards: structure-activity relationships for DNA sequence-specific alkylation”. Anticancer Drug Des. 14, 61-70
139. 1998 Binding of polybenzamides to DNA: studies by DNase 1 and chlorambucil interference footprinting and comparison with Hoechst 33258 Anti-Cancer Drug Design 14: 13, 941-954.
140. 1998 Amsacrine-induced mutations in AS52 cells Environ. Mol. Mutagen. 32, 47-55
141. 1998 Adsorption of a hydrophobic mutagen to cereal brans and cereal bran dietary fibres Mutat. Res. 412, 323-331.
142. 1998 Comparative mutational spectra of the nitrogen mustard chlorambucil and its half mustard analogue in Chinese hamster AS52 cells Mutat. Res. 401, 153-164
143. 1998 Suberized plant cell walls suppress formation of heterocyclic amine-induced aberrant crypts in a rat model Chem.-Biol. Interactions 114, 191-209
144. 1998 Mutagenic properties of topoisomerase-targeted drugs. Biochim. Biophys. Acta 1400, 213-222
145. 1998 Inhibitors of topoisomerase II enzymes: a unique group of environmental mutagens and carcinogens Mutat. Res. 400, 271-278
146. 1998 Does wheat bran or does wheat dietary fibre protect against cancer Int. J. Cancer 78, 385-386
147. 1998 Prospects for cancer prevention Mutat. Res. 428, 329-338.
148. 1997 Particle size of wheat bran in relation to colonic function in rats Food Sci. Technol. 30(7), 735-742.
149. 1997 Dietary fibre: Its role in protection against cancer”. Cellular Pharmacology 3, 389-395.
150. 1997 Micronutrients, dietary questionnaires and cancer Ferguson,LR
151. 1997 Do resistant starches as well as dietary fibres protect against colorectal cancer J. Environ. Pathology, Toxicology and Oncology 16(4), 335-341.
152. 1997 In vivo effects of chlorophyllin on the antitumour agent cyclophosphamide Int. J. Cancer 70, 84-89.
153. 1997 Overlap between mutagens and teratogens Mutat. Res. 396, 1-8.
154. 1997 Modulation of the potency of promutagens and direct-acting mutagens in bacteria by inhibitors of the multidrug resistance mechanism Mutagenesis 12, 431-435
155. 1996 Aneuploidy in germ cells: Etiologies and risk factors. Environ. Mol. Mutagen. 28, 159-166.
156. 1996 Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine Environ. Mol. Mutagen. 27(4), 255-262
157. 1996 The adsorption of heterocyclic aromatic amines by model dietary fibres with contrasting compositions Chem.-Biol. Interactions 100, 13-25
158. 1996 Mutagenicity tests as a monitoring tool for potential mutagens and carcinogens in shellfish gathering areas in New Zealand NZ Journal Marine and Freshwater Research 30, 413-421
159. 1996 Modification of the polythene glycol 6000 precipitation method for recovering human and indicator viruses from oysters and mussels NZ Journal Marine and Freshwater Research 30, 443-447
160. 1996 The clinical use of mutagenic anticancer drugs Mutat. Res. 355, 1-12.
161. 1996 Mutagenicity of anticancer drugs that inhibit topoisomerase enzymes Mutat. Res. 355, 91-102
162. 1996 Mutagenic and carcinogenic properties of platinum-based anticancer drugs Mutat. Res. 355, 59-70
163. 1996 Studies on the role of specific dietary fibres in protection against colorectal cancer” Mutation Res. 350, 173-184
164. 1996 Meiotic recombination and germ cell aneuploidy Environ. Mol. Mutagen. 28, 192-210
165. 1996 Mechanisms and targets involved in maternal and paternal age effects on numerical aneuploidy Environ. Mol. Mutagen. 28, 254-264
166. 1995 Occupational health and staff monitoring: A genetic toxicologist's viewpoint.” J. Oncol. Pharm. Practice 1(3), 49-54
167. 1995 Microbial mutagenic effects of the DNA minor groove binder pibenzimol (Hoechst 33258) and a series of mustard analogues Mutat. Res., Fundamental and Molecular Mechanisms of Mutagenesis 329(Jun), 19-27.
168. 1995 Synthesis, DNA interactions and biological activity of DNA minor groove targeted polybenzamide-linked nitrogen mustards Bioorg. Med. Chem. Lett. 3(6), 679-691.
169. 1995 The effects of a soluble-fibre polysaccharide on the adsorption of carcinogens to insoluble dietary fibres Chem.-Biol. Interactions 95(3, 14 Apr), 245-255.
170. 1995 Differences in the intake of specific food plants by Polynesians may explain their lower incidence of colorectal cancer compared to Europeans in New Zealand Nutrition and Cancer 23, 33-42
171. 1995 Anticancer drugs: An underestimated risk or an underutilised resource in mutagenesis Mutat. Res. 331, 1-26.
172. 1994 The use of 32P-postlabelling to detect DNA adducts produced by experimental anticancer drugs: DNA-directed nitrogen mustards Anti-Cancer Drug Design. 9, 239-49
173. 1994 Dietary fibre and the prevention of colorectal cancer NZ BioScience, 4-10.
174. 1994 Antimutagens as cancer chemopreventive agents in the diet Mutat. Res. 307, 395-410.
175. 1994 Topoisomerase II enzymes and mutagenicity Environ. Mol. Mutagen. 24, 245-261.
176. 1994 DNA-directed aniline mustards with high selectivity for adenine or guanine bases: mutagenesis in a variety of Salmonella typhimurium strains differing in repair-capability Mutat. Res. 321, 27-34
177. 1993 Diet and the prevention of colorectal cancer Mutat. Res. 290, 139-143
178. 1993 Multidrug resistance and mutagenesis Mutat. Res. 285, 79-90.
179. 1993 Mouse micronucleus assays of sporidesmin, the toxin associated with facial eczema in ruminants Mutat. Res. 302, 71-74
180. 1993 The size of cytokinesis-blocked micronuclei in human peripheral blood lymphocytes as a measure of aneuploidy induction by Set A compounds in the EEC tria Mutat. Res. 287, 101-112.
181. 1993 Identification of analogues of the antitumour drug amsacrine which are highly mutagenic to the yeast Saccharomyces cerevisiae Genet. (Life Sci. Adv.) 12, 1-6.
182. 1993 Induction of mitotic crossing-over by the topoisomerase-II poison DACA (N-[2-dimethylamino)ethyl]acridine-4-carboxamide) in Saccharomyces cerevisiae Mutat. Res. 289(Oct), 157-163
183. 1993 Towards reducing the incidence of colorectal cancer: The role of inheritance and diet Mutagenesis 8(4), 377-378.
184. 1993 The effects of soluble-fiber polysaccharides on the adsorption of a hydrophobic carinogen to an insoluble dietary fiber” Nutrition and Cancer 19, 43-54
185. 1993 The adsorption of a range of dietary carcinogens by a-cellulose, a model insoluble dietary fiber Mutat. Res. 319, 257-266
186. 1993 Dietary fibre: its composition and role in protection against colorectal cancer Mutat. Res. 290, 97-110
187. 1992 In vitro adsorption of a hydrophobic mutagen to gastrointestinal mucus glycoprotein (mucin) and dietary fibre Chem.-Biol. Interactions 82, 219-229.
188. 1992 Photo-enhancement of the mutagenicity of 9-anilinoacridine derivatives related to the antitumour agent amsacrine Mutat. Res. 268, 35-41.
189. 1992 Chromosomal changes in Chinese hamster AA8 cells caused by podophyllin, a common treatment for genital warts Mutat. Res. 266(2, Apr), 231-239
190. 1992 Induction of the cytoplasmic 'petite' mutation by chemical and physical agents in Saccharomyces cerevisiae Mutat. Res. 265(1, Jan), 103-148
191. 1992 Modulation of mutagenic properties in a series of DNA-directed alkylating agents by variation of chain length and alkylator reactivity Mutat. Res. 265, 181-193
192. 1992 In vitro and in vivo mutagenicity studies on sporidesmin, the toxin associated with facial eczema in ruminants Mutat. Res. 268, 199-210
193. 1992 Induction of resistance to 6-thioguanine and cytarabine by a range of anticancer drugs in Chinese hamster AA8 cells Eur. J. Cancer 28A, 736-742.
194. 1992 Cell-wall histochemistry and anatomy of taro (Colocasia esculenta Australian Journal of Botany 40, 207-222.
195. 1992 Mutagenic activities of azido analogues of amsacrine and other 9-anilinoacridines in Salmonella typhimurium and their enhancement by photoirradiation Mutat. Res. 280, 233-244
196. 1992 Adsorption of a hydrophobic mutagen to dietary fiber from taro (Colocasia esculenta), An important food plant of the South Pacific Nutrition and Cancer 17, 85-95
197. 1991 Petite mutagenesis in Saccharomyces cerevisiae by a series of bis-cationic trypanocidal drugs Antimicrob. Agents Chemother. 35(11), 2318-2321
198. 1991 The genetic toxicology of acridines Mutat. Res. 258, 123-160
199. 1991 Adsorption of a hydrophobic mutagen to dietary fibre from the skin and flesh of potato tubers Mutat. Res. 260, 203-213.
200. 1991 Variation in the mutagenic potential of acridines in Salmonella typhimurium, with stage of the culture Mutat. Res. 262, 227-231
201. 1990 Structure activity relationships for the mutagenic activity of tricyclic intercalating agents in Salmonella typhimurium Mutat. Res. 232(2, Oct), 233-241
202. 1990 Protection by inhibitors of multidrug resistance against mitochondrial mutagenesis in Saccharomyces cerevisiae Eur. J. Cancer 26(1), 55-60.
203. 1990 Mutagenic and recombinogenic consequences of DNA-repair inhibition during treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea in Saccharomyces cerevisiae Mutat. Res. 241, 369-377.
204. 1990 A model system for studying the absorption of hydrophobic mutagens to dietary fibre Mutat. Res. 244, 173-178
205. 1990 Monitoring of drug absorption by pharmacists and oncology nurses in four New Zealand Hospitals using estimation of cytokinesis-blocked micronuclei: A follow-up study in Auckland Australian Journal Hospital Pharmacology 20(3), 212-221.
206. 1990 The mutagenic effects of diacridines and diquinolines in microbial systems Mutat. Res. 232, 337-343.
207. 1990 Frameshift mutagenesis by acridines and other reversibly-binding DNA ligands. Mutagenesis 5, 529-540
208. 1990 Effects of bile salts on the absorption of a hydrophobic mutagen to dietary fibre Mutat. Res. 245, 111-117.
209. 1990 Direct-acting mutagenic properties of some hairdyes used in New Zealand Mutat. Res. 245, 41-46
210. 1990 Adsorption of a hydrophobic mutagen to five contrasting dietary preparations Mutat. Res. 262, 195-202
211. 1990 Monitoring mutagenicity in urine and peripheral blood lymphocytes of pharmacists occupationally exposed to anticancer drugs New Zealand Med. J. 103(882), 13-16
212. 1990 Genetic toxicology of tricyclic carboxamides, a new class of DNA binding antitumour agent Eur. J. Cancer 26(6), 709-714
213. 1989 Cytogenetic study of pharmacists handling cytotoxic drugs Australian Journal Hospital Pharmacology 18, 204-205.
214. 1989 Mutagenicity profiles of newer amsacrine analogues with activity against solid tumours: Comparison of microbial and mammalian systems Eur. J. Cancer Clin. Oncol. 25(2), 255-261
215. 1989 Bacterial mutagenicity studies of DNA-intercalating aniline mustards: an insight into the mode of action of a novel class of antitumour drugs Anticancer Drug Des. 4, 209-216.
216. 1989 Mutagenic activity of nitracrine derivatives in Salmonella typhimurium: Relationship to drug physiochemical parameters and to bacterial uvrB and recA genes and plasmid pKM 101 Mutat. Res. 223, 13-22.
217. 1989 A possible mechanism of toxicity by the anti-depressant amoxapine based on its effects in three in vitro models Toxicology in Vitro 3(4), 285-291.
218. 1989 Petite mutagenesis and mitotic crossing-over in yeast by DNA-targeted alkylating agents Mutat. Res. 215, 213-222.
219. 1989 Chemical carcinogens in New Zealand: What has changed in a decade? Chem. in New Zealand 53, 71-75.
220. 1988 Verapamil as a co-mutagen in the Salmonella/mammalian microsome mutagenicity test Mutat. Res. 209, 57-62.
221. 1988 Mitotic crossing-over by anticancer drugs in Saccharomyces cerevisiae strain D5 Mutat. Res. 204, 239-249.
222. 1988 Petite mutagenesis by anticancer drugs in Saccharomyces cerevisiae Eur. J. Cancer Clin. Oncol. 24(4), 591-596
223. 1988 Mutagenic and clastogenic activity of nitracrine analogues in cultured V79 Chinese hamster cells Mutat. Res. 204, 655-663
224. 1988 Petite mutagenesis in Saccharomyces cerevisiae by a series of 2,7-di-alkyl-substituted derivatives of proflavine with differing DNA-binding properties Mutat. Res. 201, 213-218.
225. 1988 Comparison of the mutagenicity of amsacrine with that of a new clinical analogue, CI-921 Mutat. Res. 204, 207-217
226. 1988 The use within New Zealand of cytogenetic approaches to monitoring of hospital pharmacists for exposure to cytotoxic drugs: report of a pilot study in Auckland Australian Journal Hospital Pharmacology 18(3), 228-233
227. 1987 Mutagenicity of nitracrine analogues in Salmonella typhimurium: Mutational specificity and activation by bacterial enzymes and rat-liver S9 Mutat. Res. 187, 1-9
228. 1987 Mutagenic, recombinogenic and antimitochondrial effects of nitracrine analogues in Saccharomyces cerevisiae Mutat. Res. 187, 209-217.
229. 1987 Frameshift mutagenesis by nitracrine analogues in wild type, uvrB, polA and recA strains of Salmonella typhimurium, with and without plasmid pKM101 Mutat. Res. 184, 13-21.
230. 1987 Anaerobic incubation and mutagenicity of nitracrine analogues in Salmonella typhimurium Mutagenesis 2(4), 253-257.
231. 1986 Chromosome damage by dothistromin in human peripheral blood lymphocyte culture: A comparison with aflatoxin B1 Mutat. Res. 170, 47-53.
232. 1986 Verapamil modulates mutagenicity of antitumor acridines in bacteria and yeast Biochem. Pharmacol. 35(24), 4581-4584.
233. 1986 Morphological transformation and chromosome damage by amsacrine in C3H/10T 1/2 clone 8 cells Mutat. Res. 170, 133-143
234. 1985 Three consistent patterns of response to substituted acridines in a variety of bacterial tester strains used for mutagenicity testing Mutat. Res. 157, 29-37.
235. 1985 Condensed tannins induce micronuclei in cultured V79 Chinese hamster cells Mutat. Res. 158, 89-95.
236. 1985 Occupational mutagenesis. J. Occup. Health Safety Aust./NZ. 1, 233-236.
237. 1985 DNA-damaging activity in ethanol-soluble fractions of feces from New Zealand groups at varying risks of colorectal cancer extracts Nutrition and Cancer 7, 93-103
238. 1984 Frameshift mutagenesis by acridines in wild type, uvrB and polA strains of Salmonella typhimurium with and without plasmid pKM101 Mutat. Res. 141, 83-88.
239. 1984 Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 Chinese hamster cells Cancer Res. 44, 4420-4431
240. 1984 Relationship between the induction of chromosome damage and cytotoxicity for amsacrine and congeners Cancer. Treat. Rep. 68(4), 625-630
241. 1984 Mitotic aneuploidy as a possible mechanism for tumour promoting activity in bile acids Carcinogenesis 5, 447-451.
242. 1984 Quantitation of free and conjugated bile acids in human feces using a high pressure liquid chromatography counterion method Analyt. Biochem. 143, 325-332
243. 1984 Apparent changes in structure-activity relationships for antimitochondrial effects of 9-anilinoacridines according to Saccharomyces cerevisiae strain and methodology Mutat. Res. 136, 223-231
244. 1983 Comparative studies of mutagenic, DNA binding, and antileukaemic properties of 9-anilinoacridine derivatives and related compounds Chem.-Biol. Interactions 44, 53-62.
245. 1983 Induction of petite mutants in yeast by non-intercalative DNA binding antitumour agents Eur. J. Cancer Clin. Oncol. 19(11), 1575-1583.
246. 1982 DNA binding and growth inhibitory properties of a series of 2,7,-dialkyl-substituted derivatives of proflavine Chem.-Biol. Interactions 42, 97-105.
247. 1981 The relationship between frameshift mutagenicity and DNA-binding affinity in a series of acridine-substituted derivatives of the experimental antitumour drug 4'-(9-acridinylamino)methanesulphonanilide (AMSA Mutat. Res. 82, 31-39
248. 1981 Induction of petite formation in Saccharomyces cerevisiae by experimental antitumour agents. Structure activity relationships for 9-anilinoacridines Mutat. Res. 90, 411-423.
249. 1980 Potential antitumor agents. 33. Quantitative structure activity relationships of mutagenic activity and antitumor activity of substituted 4'-(9-acridinylamino)methanesulfonanilide derivatives J. Med. Chem. 23, 269-274
250. 1980 The role of dimer excision in liquid holding recovery of UV-irradiated haploid yeast Mutat. Res. 69, 19-41.
251. 1979 Potential antitumor agents. 30. Mutagenic activity of some 9-anilinoacridines. Relationship between structure, mutagenic potential and antitumor activity J. Med. Chem. 22, 251-255.
252. 1979 Food and cancer Food Tech. New Zealand, 3-11
253. 1979 Food and cancer: a reply to correspondence Food Tech. New Zealand, 30-31.
254. 1978 Cancer and chemical carcinogens in New Zealand Chem. in New Zealand 42, 96-102.
255. 1974 Excision of bases accompanying the excision of dimers from DNA of UV-irradiated yeast Mol. Gen. Genetics 135, 87-90

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.